Supplementary Materials and Methods from Entrectinib, a Pan–TRK, ROS1, and ALK Inhibitor with Activity in Multiple Molecularly Defined Cancer Indications

Elena Ardini, Arturo Galvani, Patrizia Banfi et al.|Unknown|2023

Cited by 0